reviewBoneDec 10, 2010Closed access

Denosumab and bisphosphonates: Different mechanisms of action and effects

Harvard University · Massachusetts General Hospital · +4 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

707
total citations
FWCI
14.40
Percentile
100%
References
187
Citations per year

Authors

3

Topics & keywords

Keywords
  • Denosumab
  • Osteoclast
  • RANKL
  • Bone resorption
  • Bisphosphonate
  • Osteoporosis
  • Medicine
  • Bone Density Conservation Agents
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding